Peptide conjugates modified Nand/or C-terminally by short charged peptide chains

Details for Australian Patent Application No. 2001272944 (hide)

Owner Zealand Pharma A/S

Inventors Petersen, Jorgen Soberg; Larsen, Bjarne Due; Harlow, Kenneth William; Kapusta, Daniel R.

Agent Spruson & Ferguson

Pub. Number AU-B-2001272944

PCT Pub. Number WO01/98324

Priority 60/298,186 13.06.01 US; PA 2000 01486 05.10.00 DK; 60/261,671 06.12.00 US; PA 2000 00944 16.06.00 DK

Filing date 15 June 2001

Wipo publication date 2 January 2002

Acceptance publication date 29 June 2006

International Classifications

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

29 June 2006 Application Accepted

  Published as AU-B-2001272944

17 August 2006 Amendment Made

  The nature of the amendment is: Amend the priority details from 60/261,671 06 Dec 2000 US to 60/251,671 06 Dec 2000 US 2002

26 October 2006 Standard Patent Sealed

16 November 2006 Corrigenda

  Applications Accepted - Name Index Under the name Zealand Pharma A/S, Application No. 2001272944, under INID (31) correct the priority number to read 60/251,671.

20 January 2011 Assignment Registered

  Zealand Pharma A/S The patent has been assigned to Serodus AS

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001272945

2001272943